Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Pharma Industry News US biotech company Ginkgo Bioworks to merge with Soaring Eagle in $15bn deal Ginkgo Bioworks, a Boston-based biotech company, has agreed to merge with Soaring Eagle Acquisition Corp., a publicly traded… bySrinathMay 12, 2021
